Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) FCF Margin (2020 - 2021)

Rapid Therapeutic Science Laboratories' FCF Margin history spans 2 years, with the latest figure at 919773.33% for Q4 2021.

  • For Q4 2021, FCF Margin fell 92125052.0% year-over-year to 919773.33%; the TTM value through Sep 2022 reached 2843875.0%, down 286591123.0%, while the annual FY2021 figure was 468476.03%, 46707699.0% down from the prior year.
  • FCF Margin for Q4 2021 was 919773.33% at Rapid Therapeutic Science Laboratories, up from 1576422.0% in the prior quarter.
  • Across five years, FCF Margin topped out at 1477.19% in Q4 2020 and bottomed at 1576422.0% in Q3 2021.